# Asunaprevir

## Sunvepra 100mg

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OSUN                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 適應症     | Chronic hepatitis C: Treatment of chronic hepatitis C (CHC) in adult patients with hepatitis C virus (HCV) genotypes 1 or 4 and compensated liver disease, including cirrhosis. Must be administered as part of combination therapy with other anti-HCV agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量   | For hepatitis C in adults, Genotype 1b (treatment-naive or treatment-experienced, ± compensated cirrhosis): 100 mg orally twice daily for 24 weeks in combination with daclatasvir; Genotype 1 or 4 (treatment-naive or treatment-experienced, ± compensated cirrhosis): 100 mg orally twice daily for 24 weeks in combination with daclatasvir, peginterferon alfa, and ribavirin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 禁忌       | Hypersensitivity to asunaprevir or any component of the formulation; moderate or severe hepatic impairment (Child-Pugh class B or C, score 7 or greater) and with decompensated hepatic disease; concurrent use with daclatasvir, peginterferon alfa, and ribavirin in women who are pregnant or may become pregnant and men whose female partners are pregnant, may be pregnant, or plan to become pregnant; concurrent use with drugs dependent on the cytochrome P450 2D6 (CYP2D6) for clearance and for which elevated plasma concentrations are associated with serious ventricular arrhythmias and sudden death; concurrent use with moderate or strong inducers and inhibitors of CYP3A or with strong inhibitors of organic anion transporting polypeptide (OATP) 1B1 or 2B1. The following drugs are included in the manufacturer labeling as being contraindicated: atazanavir, bosentan, carbamazepine, clarithromycin, cobicistat or cobicistat-containing regimens, cyclosporine, darunavir/ritonavir, dexamethasone, diltiazem, efavirenz, erythromycin, etravirine, flecainide, fluconazole, fosamprenavir, gemfibrozil, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, modafinil, nafcillin, nelfinavir, nevirapine, oxcarbazepine, phenobarbital, phenytoin, posaconazole, propafenone, rifabutin, rifampin, rifapentine, ritonavir, saquinavir, St. John’s wort, telithromycin, thioridazine, verapamil, voriconazole                   |
| 副作用     | >10%: Central nervous system: Fatigue (12% to 39%), headache (6% to 28%), insomnia (4% to 21%), irritability (16%) Dermatologic: Pruritus (6% to 25%), skin rash (5% to 18%), alopecia (3% to 16%) Gastrointestinal: Nausea (4% to 15%) Hematologic & oncologic: Anemia (19%), neutropenia Hepatic: Increased serum AST (2% to 13%), increased serum ALT (4% to 12%) Neuromuscular & skeletal: Weakness (23%) Respiratory: Flu-like symptoms (22%) 1% to 10%: Cardiovascular: Atrial fibrillation, hypertension, syncope Central nervous system: Amnesia, anxiety, depression, disturbance in attention, dizziness, emotional lability, malaise, pain, sleep disorder, vertigo Dermatologic: Dermatitis, eczema, erythema, exfoliative dermatitis, maculopapular rash, psoriasis, seborrheic dermatitis, xeroderma Endocrine & metabolic: Weight loss Gastrointestinal: Abdominal pain, constipation, decreased appetite, diarrhea, dyspepsia, dysphagia, hemorrhoids, stomatitis, vomiting Hematologic & oncologic: Eosinophilia, leukopenia, lymphocytopenia, thrombocytopenia Hepatic: Increased serum bilirubin (1% to 10%), hyperbilirubinemia Infection: Influenza Neuromuscular & skeletal: Arthralgia, back pain, musculoskeletal chest pain, myalgia Ophthalmic: Xerophthalmia Respiratory: Cough, dyspnea, dyspnea on exertion, nasopharyngitis, oropharyngeal pain Miscellaneous: Fever <1% (Limited to important or life-threatening): Erythema multiforme |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 哺乳期建議 | Human Data Suggest Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

